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Abstract
Background: Although guidelines for critical appraisal of diagnostic research and meta-analyses
have already been published, these may be difficult to understand for clinical researchers or do not
provide enough detailed information.
Methods: Development of guidelines based on a systematic review of the evidence in reports of
systematic searches of the literature for diagnostic research, of methodological criteria to evaluate
diagnostic research, of methods for statistical pooling of data on diagnostic accuracy, and of
methods for exploring heterogeneity.
Results: Guidelines for conducting diagnostic systematic reviews are presented in a stepwise
fashion and are followed by comments providing further information. Examples are given using the
results of two systematic reviews on the accuracy of the urine dipstick in the diagnosis of urinary
tract infections, and on the accuracy of the straight-leg-raising test in the diagnosis of intervertebral
disc hernia.
Background
Systematic reviews and meta-analyses of studies evaluat-
ing the accuracy of diagnostic tests (we will refer to them
generically as diagnostic systematic reviews) are appearing
more often in the medical literature [1,2]. Of the 26 re-
views on diagnostic tests published between 1996 and
1997, 19 were systematic reviews or meta-analyses[2]. In
the field of clinical chemistry and haematology, 23 of 45
reviews published between 1985 and 1998 were systemat-
ic reviews [3]. Although guidelines for critical appraisal of
diagnostic research and meta-analyses have already been
published [1,4–9], these may be difficult to understand
for clinical researchers or do not provide enough detailed
information.
We want to present a set of practical guidelines, based on
evidence and the expertise of the Cochrane Collaboration,
to facilitate understanding of and appropriate adherence
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to methodological principles when conducting diagnostic
systematic reviews.
We reviewed reports of systematic searches of the litera-
ture for diagnostic research [10–13], methodological cri-
teria to evaluate diagnostic research [1,4–9], methods for
statistical pooling of data on diagnostic accuracy [9,14–
22], and methods for exploring heterogeneity [23–27].
Guidelines for conducting diagnostic systematic reviews
are presented in a stepwise fashion and are followed by
comments providing further information. Examples are
given using the results of two systematic reviews on the ac-
curacy of the urine dipstick in the diagnosis of urinary
tract infections[28], and on the accuracy of the straight-
leg-raising test in the diagnosis of intervertebral disc her-
nia[29]. Still, clinical readers are advised to look for assist-
ance of a statistician when it comes to pooling.
The guidelines
• How to search the literature for studies evaluating the 
accuracy of diagnostic tests
A systematic review should include all available evidence,
so a systematic and comprehensive search of the literature
is needed. The reviewer has to design a search strategy
based on a clear and explicit description of the subjects re-
ceiving the test of interest, the diagnostic test and its accu-
racy estimates, the target disease, and the study design.
These elements are usually specified in the criteria for in-
clusion of primary studies in the review. The search will
include electronic literature databases. However, because
computerised databases only index a subset of all the
available literature, the search should be extended using
other resources (including reference checking and consul-
tation of experts, as explained below) [11].
The search to identify primary studies may follow the next
basic but labour-intensive steps:
1) A computer-aided search of MEDLINE (PUBMED web-
site  [http://www.ncbi.nlm.nih.gov/entrez], EMBASE and
other databases. A search strategy begins by creating a list
of database-specific keywords and text words that describe
the diagnostic test and target disease of interest (subject-
specific strategy). Because the number of diagnostic accu-
racy studies is often small, the subject-specific strategy
usually yields a limited number of publications to be
screened[12]. An accurate search strategy for diagnostic
publications (generic strategy) was recently published
[13] and can be combined with the subject-specific strate-
gy if the number of publications resulting from the latter
is large. We found a combination of two published gener-
ic strategies adapted for use in PubMed (MEDLINE) to be
more sensitive and precise than previously published
strategies[10,12] (Table 1). Each electronic database will
need to be searched using a specially designed search strat-
egy.
2) The reference section of primary studies, narrative re-
views, and systematic reviews should be reviewed to
search for additional primary studies that could have been
missed by the electronic search. Identification methods
for systematic reviews have also been published [30]. The
MEDION database available at the University of Maas-
tricht, the Netherlands, collects some 250 published re-
views of diagnostic and screening studies. It is available
through berna.schouten@hag.unimaas.nl and will short-
ly be published on the Internet.
3) Consultation of experts in the disease of interest to
identify further published and unpublished primary stud-
ies. As diagnostic accuracy studies are often based on rou-
tinely collected data, publication bias may be more
prevalent in diagnostic than in therapeutic research [19].
Comments
The first step in a literature search is the identification of
relevant publications. Diagnostic research reports, older
publications in particular, are often poorly indexed in the
electronic databases. It is often fruitful to conduct pilot
searches using the subject-specific strategy. This process is
iterated after identifying and incorporating additional
keywords and text words used to describe and index the
retrieved reports. Studies found only on the reference sec-
tions of the retrieved reports but missed by the search
strategy should be searched in the database using the arti-
cles' title or first author's name. If a study is found in the
database, its keywords should be noted and added to the
strategy. Citation tracking may provide additional studies.
The Science Citation Index could be searched forward in
time to identify articles citing relevant publications[31].
Table 1: Search strategy in PubMed (MEDLINE) for publications 
about the evaluation of diagnostic accuracy.
(((((((((((("sensitivity and specificity"[All Fields] OR "sensitivity and 
specificity/standards"[All Fields]) OR "specificity"[All Fields]) OR 
"screening"[All Fields]) OR "false positive"[All Fields]) OR "false nega-
tive"[All Fields]) OR "accuracy"[All Fields]) OR (((("predictive 
value"[All Fields] OR "predictive value of tests"[All Fields]) OR "pre-
dictive value of tests/standards"[All Fields]) OR "predictive values"[All 
Fields]) OR "predictive values of tests"[All Fields])) OR (("reference 
value"[All Fields] OR "reference values"[All Fields]) OR"reference val-
ues/standards"[All Fields])) OR ((((((((((("roc"[All Fields] OR "roc 
analyses"[All Fields]) OR "roc analysis"[All Fields]) OR "roc and"[All 
Fields]) OR "roc area"[All Fields]) OR "roc auc"[All Fields]) OR "roc 
characteristics"[All Fields]) OR "roc curve"[All Fields]) OR "roc curve 
method"[All Fields]) OR "roc curves"[All Fields]) OR "roc esti-
mated"[All Fields]) OR "roc evaluation"[All Fields])) OR "likelihood 
ratio"[All Fields]) AND notpubref [sb]) AND "human"[MeSH Terms])BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/9
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Once the search is completed, two independent reviewers
should screen the titles and abstracts of the identified cita-
tions by using specific pre-specified inclusion criteria. The
inclusion criteria can be pilot tested on a sample of arti-
cles. If disagreements cannot be resolved by consensus or
if insufficient information is available, a third reviewer
and/or the full papers should be consulted.
• Criteria for inclusion of studies
Reference test
The accuracy of a diagnostic or screening test should be
evaluated by comparing its results with a 'gold standard',
criterion standard or reference test accepted as the best
available by content experts. The reference test may be a
single test, a combination of different tests, or the clinical
follow-up of patients [22]. The publication should de-
scribe the reference test since it is a conditio sine qua non for
the evaluation of a diagnostic test.
Population
Detailed information about the participants in diagnostic
research is often lacking. Participants should be defined
explicitly in terms of age, gender, complaints, signs and
symptoms, and their duration. At least, a definition of par-
ticipants with and without the disease, as determined by
the reference test, should be available. The minimal
number of participants needed with and without the dis-
ease depends of the type of study, the estimates of diag-
nostic accuracy, and the precision used to estimate these
parameters [32].
Outcome data
Information should be available to allow the construction
of the diagnostic 2 by 2 table with its four cells: true posi-
tives, false negatives, false positives and true negatives.
Language
If a review is limited to publications in certain languages,
it should be reported.
Comments
As the patient mix (spectrum of disease severity) is differ-
ent at different levels of care, a diagnostic review may fo-
cus on a specific setting (primary care, etc.) or include all
levels. This information may be important for subgroup
analyses in case of heterogeneity. If test characteristics
have changed over the years as a result of changing meth-
ods or technological evolution, one may consider the in-
clusion of only studies that used the new version of the
testing [33]. However, as advocated for systematic reviews
of trials by the Cochrane Collaboration, all published re-
search may be included: in the analysis the association
with time may be studied and explained. All evidence
available should be reviewed regardless of their language
of publication. It is not easy to identify non-English pub-
lications, as they are often not indexed in computerised
databases. In the field of intervention research, there is
some evidence of bias when excluding non-English publi-
cations [34]. Our research on the accuracy of the urine
dipstick revealed differences in the methodological valid-
ity between European and American studies, but these dif-
ferences had no effect on accuracy. Although large
samples are no guarantee against selective patient sam-
pling, small samples seldom result from a consecutive se-
ries of patients or a random sample, but often constitute a
convenience sample. Small samples are, therefore, very
vulnerable to selection bias.
• Methodological quality
The methodological quality of each selected paper should
be assessed independently by at least two reviewers.
Chance-adjusted agreement should be reported and disa-
greements solved by consensus or arbitration. To improve
agreement, reviewers should pilot their quality assess-
ment tools in a subset of included studies or studies eval-
uating a different diagnostic test.
Validity criteria for diagnostic research have been pub-
lished by the Cochrane Methods Group on Screening and
Diagnostic Tests [35] [http://www.cochrane.org/co-
chrane/sadt.htm], and by other authors [4–6], [8,9]. Cri-
teria, assessing internal and external validity, should be
coded and described explicitly in the review (Table 2). The
internal validity criteria refer to study characteristics that
safeguard against the intrusion of systematic error or bias.
External validity criteria provide insight into the generalis-
ibility of the study and judge if the test under evaluation
was performed according to accepted standards. Internal
and external validity criteria, describing participants, diag-
nostic test and target disease of interest, and study meth-
ods may be used in meta-analysis to assess the overall
'level of evidence' and in sensitivity and subgroup analy-
ses (see Data Extraction and Data Analysis sections).
It is important to remember that studies may appear to be
of poor methodological quality either because they were
poorly conducted or poorly reported. Methodological ap-
praisal of the primary studies is frequently hindered by
lack of information. In these instances, reviewers may
choose to contact the studies' authors or score items as
'don't know or unclear'.
Example
A urine dipstick is usually read before the material is cul-
tured. So, it can be interpreted that the dipstick was read
without awareness of the results of the urine culture.
However, the culture (reference test) may be interpreted
with full awareness of the results of the dipstick. If blind-
ing is not explicitly mentioned, reviewers may choose to
score this item as 'don't know' or 'diagnostic test blindedBMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/9
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for reference test' (implicitly scoring the reference test as
not blinded). Or, the authors may be contacted for clarifi-
cation.
A survey of the diagnostic literature from 1990 through
1993 in a number of peer-reviewed journals, showed that
only a minority of the studies satisfied methodological
standards [7]. There is some evidence that inadequate
methods may have an impact on the reported accuracy of
a diagnostic test: Lijmer [2] screened diagnostic meta-
analyses published in 1996 and 1997, and showed that
the diagnostic accuracy of a test was overestimated in
studies 1) with a case-control design; 2) using different
reference tests for positive and negative results of the in-
dex test; 3) accepting results of observers that were un-
blinded to the index test results when performing the
reference test; 4) that did not describe diagnostic criteria
for the index test; and 5) where participants were inade-
quately described.
Comments
Ideally, all participants should be submitted to the same
reference test. Sometimes different groups of patients are
submitted to different reference tests, but details are not
given. In this case, it is important to assess if the different
reference tests are recognised by experts as being ade-
quate. In some conditions results of the index test may be
incorporated into the diagnostic criteria, what may lead to
incorporation bias and overestimation of accuracy [36].
Verification or work-up bias may be present if not all par-
ticipants who received the index test, are referred to the
reference test(s). Verification bias is present if the partici-
pants are referred according to the index test results. That
is usually the case in screening studies where only subjects
with positive index test results receive the reference test, so
that only a positive predictive value can be calculated. Es-
timation of accuracy will not be possible in these studies
unless complete follow-up registries are available. In case-
control studies the contrast between diseased and non-
diseased may be artificially sharpened by sampling only
persons who are clearly diseased and persons who are
completely healthy, resulting overestimated sensitivity
and specificity[36].
• Data extraction
Two reviewers should independently extract the required
information from the primary studies. Detailed informa-
tion has to be extracted about the participants included in
Table 2: List of validity criteria operationalised for papers reporting on the accuracy of urine dipsticks in the diagnosis of Urinary Tract 
Infections (UTI) or Bacteriuria
Criteria of internal validity (IV) Positive score
Valid reference standard (semi-)quantitative (2 points) ot dipslide culture (1 point)
Definition of cut-off point for reference standard definition of Urinary Tract Infection/Bacteriuria by colony forming units per ml (1 point)
Blind measurement of index test and reference test in both directions (2 points) or only index or reference test
Avoidance of verification bias assessment by reference standard independent from index test results (1 point)
Index test interpreted independently of all clinical 
information
explicitly mentioned in the publication or urine samples from mixed out-patient populations 
examined in a general laboratory (1 point)
Design prospective (consecutive series) (1 point) or retrospective collection of data (0 points)
Criteria of external validity (EV)
1 Spectrum of disease in- and/or exclusion criteria mentioned (1 point)
2 Setting enough information to identify setting (1 point) (community through tertiary care)
3 Previous tests/referral filter details give about clinical and other diagnostic information as to which the index test is 
being evaluated (symptomatic or asymptomatic patients (1 point)
4 Duration of illness before diagnosis duration mentioned (1 point)
5 Co-morbid conditions details given (type of population) (1 point)
6 Demographic information age (1 point) and/ or gender (1 point) data provided
7 Execution of index test information about standard procedure directly or indirectly available, urine collection pro-
cedure, first voided urine, distribution of micro-organisms, procedure of contaminated 
urine samples, time of transportation of urine sample, way of reading index test, persons 
reading index test (1 point each)
8 Explicitation of cut-off point of index test trace, 2 or more + (1 point if applicable)
9 Percentage missing if appropriate: missings mentioned (1 point)
10 Reproducibility of index test reproducibility studied or reference mentioned (1 point)
Blinding (IV3): When information about blinding of measurements was not given and the dipstick was performed in another setting than the culture, 
we assumed blind assessment of the index test versus the reference test but not vice versa. Explicitation of the cut-off point (EV8) was only necessary 
for the leukocyte-esterase measurement.BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/9
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the study, time of data collection and the testing proce-
dures. The cut-off point used in dichotomous testing and
the reasons and the number of participants excluded be-
cause of indeterminate results or unfeasibility is always re-
quired.
Example
Detailed information extracted in the case of the dipstick
meta-analysis: mean age, male/female ratio, different cut-
off points for leukocyte-esterase (trace, 2+, 3+), time need-
ed for transportation, if indeterminate results were exclud-
ed, included as negative or repeated.
As the information extracted may be used in subgroup
analyses and statistical pooling of the validity, possible
sources of heterogeneity should be defined based on a pri-
ori existing evidence or hypotheses.
Example
In the dipstick meta-analysis we hypothesised that the fol-
lowing factors may explain heterogeneity if present: pro-
cedures of collection of material for the test (method of
urine collection, delay between urine collection and cul-
ture), who was executing the test and how (manually or
automatic), and different brands of commercial products.
Accuracy may be presented in different ways. For the
meta-analysis of dichotomous tests (see below) it is nec-
essary to construct the diagnostic 2 ×  2 table: absolute
numbers in the four cells are needed. Totals of 'diseased'
and 'non-diseased' participants are needed to calculate
prior probability (pre-test probability), and to reconstruct
the 2 ×  2 table from sensitivity, specificity, likelihood ra-
tios, predictive values or receiver-operator characteristic
(ROC) curves. If possible, the 2 ×  2 table should be gener-
ated for all relevant subgroups. Further information to ex-
tract includes year of publication, language of
publication, and country or region of the world where the
study was performed.
Comments
A standardised data extraction form may be used simulta-
neously with but separately from the quality assessment
form. This approach facilitates data extraction and com-
parison between reviewers. The form has to be piloted to
ensure that all reviewers interpret data in the same way.
Like in other steps of the review were judgements are
made, disagreements should be recorded and resolved by
consensus or arbitration. Lack of details about test results
or cut-off points, inconsequential rounding off of percent-
ages, and data errors require common sense and careful
data handling when reconstructing 2 ×  2 tables. If predic-
tive values are presented with sensitivity and specificity in
'diseased' and 'non-diseased' individuals, the calculation
of the four cells from sensitivity and specificity can be con-
firmed by using the predictive values. Details can be re-
quested from the authors of the studies, but these
attempts are often unsuccessful, as the raw data may no
longer be available.
Example
In a review on the accuracy of the CAGE questionnaire for
the diagnosis of alcohol abuse, sufficient data were made
available of 9 only out of 22 studies selected, although the
authors of the review tried to contact the original authors
by all means [37].
• Data analysis
Whether or not meta-analysis – statistical analysis and cal-
culation of a summary diagnostic accuracy estimate – can
be conducted depends on the number and methodologi-
cal quality of primary studies included and the degree of
heterogeneity of their estimates of diagnostic accuracy. Be-
cause diagnostic accuracy studies are often heterogeneous
and present limited information it is typically difficult to
complete a meta-analysis. If heterogeneity is identified,
important information is obtained from attempts to ex-
plain it. For instance, the effect that each validity criterion
has on the estimates of diagnostic accuracy and the influ-
ence of a priori defined study characteristics should be ex-
plored as potential explanations of the observed study-to-
study variation [23–27]. If meta-analysis is not possible or
advisable, the review can be limited to a qualitative de-
scriptive analysis of the diagnostic research available (best
evidence synthesis) [38].
Several meta-analytic methods for diagnostic research
have been published in the last decennium [14–22]. For
the analysis we recommend the following steps: 1-presen-
tation of the results of individual studies, 2-searching for
the presence of heterogeneity, 3-testing of the presence of
an (implicit) cut-point effect, 4-dealing with heterogenei-
ty, 5-deciding which model should be used if statistical
pooling is appropriate and 6-statistical pooling.
• Describing the results of individual studies
Reporting the main results of all included studies is an es-
sential part of each review. It provides the reader the out-
come measures and gives at a first glance insight in their
heterogeneity. Each study is presented with some back-
ground information (year of publication, geographical re-
gion, number of diseased and non-diseased patients,
selection of the patients, methodological characteristics)
and a summary of the results. In view of the asymmetric
nature of most diagnostic tests (some tests are good to ex-
clude a disease, others to confirm), it is important to re-
port pairs of complimentary outcome measures, i.e. at
least both sensitivity and specificity, as this is necessary in-
formation for readers who would like to reproduce the
systematic review. The diagnostic odds ratio (DOR) canBMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/9
Page 6 of 13
(page number not for citation purposes)
be added, but better not alone, as a same odds ratio can
relate to different combinations of sensitivity and specifi-
city. The DOR is a measure for the discriminative power of
a diagnostic test: the ratio of the odds of a positive test re-
sult among diseased to the odds of a positive test result
among the non-diseased.
For more details regarding the calculation of the DOR
based on the study-specific sensitivity and specificity we
refer to Littenberg [15], Midgette [16] or Moses [17]. The
potential problems associated with sensitivities and spe-
cificities of 100% are solved by adding 0,5 to all cells of
the diagnostic 2 ×  2 table. Main outcome measures should
always be reported with their 95% confidence intervals
(CI).
• Searching for heterogeneity
When setting inclusion criteria, most reviewers will try to
define a more or less homogeneous set of studies. Reality
is however, that even then most diagnostic reviews show
considerable heterogeneity in the results of included stud-
ies. When different studies have largely different results,
this may result from either random error or heterogeneity
due to differences in clinical or methodological character-
istics of studies. A chi-square test or an extension of the
Fisher's exact test for small studies [39] can be used to sta-
tistically test the presence of heterogeneity in study results.
This may offer some guidance, but the power of this test
tends to be low. A basic, but very informative method for
assessing heterogeneity is to produce a graph in which the
individual study-outcomes are plotted, together with their
95% confidence intervals (Figure 1), and subjectively
evaluate the variation in study results.
• Searching for the presence of an (implicit) cut-off point 
effect
Estimates of diagnostic accuracy differ if not all studies use
the same cut-off point for a positive test result or for the
reference standard. The interpretation of test results often
depends on human factors (e.g. radiology, pathology, etc)
or on the process of testing (e.g. clinical examination). In
such cases different studies may use a different implicit
cut-off point. Variation in the parameters of accuracy may
be partly due to variation in cut-off points. In case of diag-
nostic tests with a continuous or ordinal outcome the
ROC curve presents pairs of sensitivity and specificity for
different values of the cut-off point of a test.
One can test for the presence of a cut-off point effect be-
tween studies by calculating a Spearman correlation coef-
ficient between sensitivity and specificity of all included
studies. If strongly negatively correlated, pairs of parame-
ters represent the same DOR [17]. A strong correlation be-
tween both parameters will usually result in a
homogeneous logarithmic transformed DOR (lnDOR).
Example
In a systematic review of the urine dipstick studying the
accuracy of nitrites for the diagnosis of urinary tract infec-
tions [28], sensitivity and specificity were poorly correlat-
ed (Spearman ρ  = -0.377) and highly heterogeneous in 58
studies. So was the lnDOR. Subgroup analysis of the factor
'setting of care' gave the results in Table 3.
The Spearman ρ  indicates a strong cut-off effect in the
family medicine studies and to a lesser degree in the emer-
gency department studies. Despite heterogeneity of sensi-
tivity and specificity, the pairs of sensitivity and specificity
in the 6 family practice studies presented a homogeneous
DOR.
Moses et al. [17] mention a Spearman correlation of ρ  < -
0.6, but evidence is still limited (see example above: a ρ  of
-0.4 results in a homogeneous lnDOR). The test for ho-
mogeneity of the lnDOR is described in Fleiss [39]. If the
lnDOR of the included studies are homogeneous, a Sum-
mary ROC curve (SROC) can be fitted based on the pairs
of sensitivity and specificity of the individual studies (see
further). If sufficient information is available also the
pooling of ROC curves of individual studies will be possi-
ble.
4. Dealing with heterogeneity
• Dealing with heterogeneity
In many cases the interpretation of observed heterogenei-
ty is the most fascinating and productive part of a meta-
analysis. The inspection of the plot of sensitivity, specifi-
city and DOR with their 95% CI may indicate the presence
of outliers. In that case the reason for this situation should
carefully be examined.
Example
In the straight-leg-raising test review the plots of sensitivi-
ty and specificity showed clear heterogeneity, confirmed
by statistical testing. The plot of the DOR revealed one
outlier study (figure 1).
In such cases an outlier can be excluded and the analysis
continued with the homogeneous group of remaining
studies. Deviant results should be explored and explained.
The decision to exclude outliers is complex and should be
handled in the same way as in other fields of research.
Outliers can also be searched by using a Galbraith plot
[40]. To construct this plot, the standardised lnDOR =
lnDOR/se is plotted (y-axis) against the inverse of the se
DOR = 
sensitivity / (1 - sensitivity)
(1 - specificity) / sp pecificityBMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/9
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Figure 1
Point estimates (with confidence limits) of respectively sensitivity, specificity, and diagnostic odds ratio of 11 studies on the
validity of the test of Lasègue for the diagnosis of disc hernia in low back pain. Study 6 is an outlier
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(1/se) (x-axis). A regression line that goes through the or-
igin is calculated, together with 95% boundaries (starting
at +2 and -2 on the y-axis). Studies outside these 95%
boundaries may be considered as outliers (Figure 2).
Subgroup analyses defined a priori in the protocol could
be conducted to detect homogeneous subgroups. Analysis
of variance with the lnDOR as dependent variable and cat-
egorical variables for subgroups as factors can be used to
look for differences among subgroups.
Example
In the dipstick review, sensitivity and specificity were
weakly associated (ρ  = -0.337) and very heterogeneous.
Subgroup analysis showed significant differences of the
lnDOR between 6 different 'populations of participants'.
In three populations (general population, pregnant wom-
en and surgery patients) there was a strong negative asso-
ciation between sensitivity and specificity (ρ  = -0.539, -
0.559, and -1.00 respectively), yielding homogeneous
lnDOR in the three subgroups. Different SROC curves for
each subgroup could be fitted (see 6.1.2) (Figure 3).
If many studies are available, a more complex multivariate
model can be built in which a number of study character-
istics are entered as possible co-variates. Multivariate
models search for the independent effect of study charac-
teristics, adjusted for the influence of other, more power-
ful ones.
• Deciding on the model to be used for statistical pooling
Models
There are two underlying models that can be used when
pooling the results of individual studies.
A fixed effect model assumes that all studies are a certain
random sample of one large common study, and that dif-
ferences between study outcomes only result from ran-
dom error. Pooling is simple. It essentially consists of
calculating a weighted average of the individual study re-
sults. Studies are weighted by the inverse of the variance
of the outcome parameter of test accuracy.
A random effect model assumes that in addition to the pres-
ence of random error, differences between studies can also
result from real differences between study populations
and procedures. The weighting factor is mathematically
more complex, and is based on the work of Der Simonian
and Laird, initially performed and published for the meta-
analysis of trials [41]. It includes both within-study and
between-study variation.
A more detailed description about these models can be
found in Rutter and Gatsonis [20,42].
Homogeneous studies
If sensitivity and specificity are homogeneous, and if they
show no (implicit) cut-off effect (see above), they can be
pooled and a fixed effect model can be used. If there is ev-
idence of a cut-off effect, SROC curves can be constructed
(see below) or ROC curves can be pooled.
Heterogeneous studies
If heterogeneity is present, the reviewer has the following
options:
1. Refrain from pooling and restrict the analysis to a qual-
itative overview.
2. Sub-group analysis if possible on prior factors and
pooling within homogeneous sub-groups.
3. As a last resort, pooling can be performed, using meth-
ods that are based on a random effect model.
In view of the low methodological quality of most of the
diagnostic studies that have been carried out, there is a
tendency to advise using random effect models for the
pooling of all diagnostic studies, even if there is no appar-
ent heterogeneity.
• Statistical pooling (please see additional file 1: appendix
statistical formulae for further information)
Table 3: 
Family Medicine (n = 6) Outpatients clinics (n = 17) Hospital (n = 16) Emergency (n = 4)
Spearman ρ -0.714 -0.287 -0.228 -0.400
Sensitivity heterogeneous heterogeneous heterogeneous homogeneous
Specificity heterogeneous heterogeneous heterogeneous heterogeneous
InDOR homogeneous heterogeneous heterogeneous homogeneousBMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/9
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1. Pooling of proportions
1.1. Homogeneous sensitivity and/or specificity
If fixed effect pooling can be used, pooled proportions are
the average of all individual study results, weighted for the
sample sizes. This is easily done by adding together all nu-
merators and dividing the total by the sum of all denom-
inators [16].
1.2. Cut-off point effect: SROC curve
The SROC curve is presented with sensitivity on the y-axis
and 1-specificity on the x-axis (ROC plot). The SROC
curve differs from the ROC curve in primary diagnostic re-
search, as each study provides one value of sensitivity and
one value of specificity (Figure 3). If a SROC curve can be
fitted, a regression model is used, with the natural loga-
rithm of the DOR (lnDOR) of the primary research as de-
pendent variable and two parameters as independent
variables: one for the intercept (to be interpreted as the
mean lnDOR) and one for the slope of the curve (as an es-
timate of the variation of the lnDOR across the studies
due to threshold differences). Details and formula for fit-
ting the curve can be found in the paper presented by Lit-
tenberg and Moses [15]. Co-variates representing different
study characteristics or pre-test probabilities can be added
to the model to examine any possible association of the
diagnostic odds ratio with these variables [43]. This type
of analysis is usually referred to meta-regression, and re-
fers to (multivariate) regression of the summary estimate
DOR of primary research as the dependent variable, and
characteristics of the included studies as independent var-
iables. The pooled lnDOR and confidence bounds have to
be back-transformed into a diagnostic odds ratio and its
confidence intervals. This meta-regression model can be
unweighted or weighted, using the inverse of the variance
as the weighting factor. The often-negative association of
the weighting factor with the lnDOR gives studies with
lower discriminative diagnostic odds ratios – because of
lower sensitivity and/or specificity – a larger weight. This
may be a problem when comparing the pooled accuracy
of different tests, and has not yet been solved [19,21].
2. Pooling of likelihood ratios
Continuous test results can be transformed into likeli-
hood ratios[9] obtained by using different cut-off points.
Individual data-points from the selected studies can be
used to calculate result-specific likelihood ratios[44],
which can be obtained by logistic modelling. The natural
log posterior odds is converted into a log likelihood ratio
by adding a constant to the regression equation. The con-
stant adjusts for the ratio of the number of 'non-diseased'
to 'diseased' participants in the respective studies [19].
If primary studies present ordinal test results and they use
the same number of categories, ROC curves can be con-
structed for each study and pooled as below or by using
ordinal regression methods [19,45]
3. Pooling of the ROC curves
Results of diagnostic studies with a dichotomous gold
standard outcome, and a test result that is reported on a
continuous scale, are generally presented as a ROC curve
with or without the related area under the curve (AUC)
and its 95% CI. To pool such results, the reviewer has
three options: to pool sensitivities and specificities for all
Figure 2
Galbraith plot of 11 studies on the validity of the test of
Lasègue for the diagnosis of disc hernia in low back pain.
Study 6 is an outlier.
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Figure 3
Summary ROC curves of nitrites in urine dipsticks for the
diagnosis of bacteriuria and urinary tract infections in various
homogeneous subgroups of patient populations.
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relevant cut-off points, to pool the AUCs, or to model and
pool the ROC curves themselves.
A. A pooled ROC curve and its confidence interval can be
constructed on the basis of the pooled sensitivity / specif-
icity values per cut-off point. To make this possible, suffi-
cient raw data have to be available, which is seldom the
case.
B. The AUC, like all one-dimensional measures, provides
no information about the asymmetric nature of a diagnos-
tic test. It cannot distinguish between curves with a high
sensitivity at moderate values of the specificity and curves
with a high specificity at moderate values of the sensitivi-
ty.
C. As ROC curves are based on ranking, they are robust
with respect to inter-study shifts in the value or the mean-
ing of cut-off points. They also provide information about
the asymmetrical nature of the test information. To enable
direct pooling of ROC curves, a method has been devel-
oped that requires only the published curves and the
number of positive and negative participants on the gold
standard test as input [46]. The ROC curve is scanned into
a graphic computer file and then converted into a series of
sensitivity versus specificity data, using appropriate soft-
ware or, ultimately, by hand. Subsequently, a model is fit-
ted for each study, similar to the model that is used for
producing SROC curves.
For continuous scale tests, weighted linear regression is
used to estimate the parameters for each curve, including
a bootstrap method to estimate the standard errors. For
ordinal tests, maximum likelihood estimation yields the
parameters and their standard errors [46].
The resulting estimates are pooled separately, using a ran-
dom effect model, and the resulting model is back-trans-
formed into a new-pooled curve with its 95% confidence
band.
In addition to causing calculation problems in specific sit-
uations, pooling published ROC curves also hides the test
values from the picture. Although this is not a problem
when evaluating a test method, or when comparing differ-
ent methods, it limits the possible use of the pooled curve
for evaluating the diagnostic value of each specific test re-
sult. Moreover, a published curve can be a fitted estimate
of the real curve based on the initial values, and any bias
resulting from this estimation will be included in the
pooled estimates.
Data presentation
A DOR is difficult to interpret because it is a combination
of sensitivity and specificity [9]. However, it is useful to
present pooled sensitivity and specificity estimates, to-
gether with the relevant diagnostic odds ratios for differ-
ent study characteristics or sub-groups (all estimates with
their respective confidence intervals). To make this infor-
mation accessible to clinicians, the predictive values could
be obtained by using the mean prior (pre-test) probabili-
ties of each sub-group. Alternatively, likelihood ratios
could be reported so that users can calculate post-test
probabilities based on the pre-test probabilities applica-
ble to their patients.
Example taken from the dipstick review: see Table 4.
Pooled DOR (and confidence intervals) of different sub-
groups can also be presented graphically on a logarithmic
scale to end up with symmetric confidence intervals and
to reduce the width.
Example taken from the straight-leg-raising test review. In
Figure 4 the DOR and confidence boundaries are plotted
on the y-axis on a logarithmic scale. Relevant study char-
acteristics (i.e., double-blind versus single-blind studies,
studies with or without verification bias) are plotted on
the x-axis.
Discussion
While the methodology to conduct a systematic review
and meta-analysis of diagnostic research is developed up
to a certain extent, at least for dichotomised tests, the ex-
ercise itself remains quite a challenge. Systematic reviews
have to meet high methodological standards and the re-
sults should always be interpreted with caution. Several
complicating issues need careful consideration: 1) it is dif-
Table 4: 
Factor DOR (95% CI) Sensitivity (95% CI) Specificity (95% CI) Prior probability PPV NPV
Mixed Population 11 (6–21) 0.50 (0.44–0.58) 0.82 (0.71–0.95) 0.32 0.57 0.78
Surgery 34 (25–47) 0.54 (0.39–0.74) 0.96 (0.93–0.99) 0.20 0.76 0.89BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/9
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ficult to discover all published evidence, as diagnostic re-
search is often inadequately indexed in electronic
databases; 2) the research methods and characteristics of
study population and test procedures are often poorly re-
ported in primary research [1,7]; a set of minimal report-
ing standards for diagnostic research has only recently
been discussed: Standards for Reporting of Diagnostic Ac-
curacy-statement (STARD)  [http://www.consort-state-
ment.org/] Further Initiatives); 3) the methodological
quality and validity of diagnostic research reports is often
limited (i.e., no clear definition of 'diseased' participants,
no blinding, no independent interpretation test results,
insufficient description of participants) [2,7]; 4) accuracy
estimates are often very heterogeneous, yet examining het-
erogeneity is cumbersome, and the process is full of pit-
falls; 5) results have to be translated into information that
is clinically relevant, taking into account the clinical reali-
ty at different levels of health care (prevalence of disease,
spectrum of disease, available clinical and other diagnos-
tic information). Even in a state-of-the-art systematic re-
view, the reviewers have to make many subjective
decisions when deciding on inclusion or exclusion of
studies, on quality assessment and interpretation of limit-
ed information, on the exclusion of outliers, and on
choosing and conducting subgroup analyses. Subjective
aspects have to be assessed independently by more than
one reviewer with tracking of disagreements and resolu-
tion by consensus or arbitration. These subjective deci-
sions should be explicitly acknowledged in the report to
allow the readers some insight into the possible conse-
quences of these decisions on the outcomes of the review
and the strength of inference derived from it.
While some researchers question the usefulness of pool-
ing the results of poorly designed research or meta-analy-
sis based on limited information [47,48], we think that
examining the effects of validity criteria on the diagnostic
accuracy measures and the analysis of subgroups adds val-
uable evidence to the field of diagnostic accuracy studies.
The generation of a pooled estimate, the most likely esti-
mate of the test's accuracy, provides clinicians with useful
information until better-conducted studies are published.
The reader should remember that evidence about the ef-
fect of different aspects of internal or external validity on
the results of diagnostic accuracy is still limited [2,3,6].
Consequently, it is difficult to recommend a strict set of
methodological criteria at this moment, recognizing that
there is, as yet, insufficient evidence to support the use of
any minimum set of criteria. Although we have discussed
some practical approaches to statistical pooling, other
methods are available in the literature [19–21]. Experi-
ence with these methods however is yet limited. The de-
velopment of guidelines for systematic reviews of tests
with continuous or ordinal outcomes, reviews of diagnos-
tic strategies of more than one test, and reviews of repro-
ducibility of diagnostic tests remain another challenge, as
the methodology is still limited[1] or even non-existing.
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